LOTEMAX Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Lotemax, and when can generic versions of Lotemax launch?
Lotemax is a drug marketed by Bausch And Lomb Inc, Bausch And Lomb, and Pharmos. and is included in five NDAs. There are two patents protecting this drug.
The generic ingredient in LOTEMAX is loteprednol etabonate. There are ten drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the loteprednol etabonate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Lotemax
A generic version of LOTEMAX was approved as loteprednol etabonate by SENTISS on April 17th, 2019.
Summary for LOTEMAX
US Patents: | 0 |
Applicants: | 3 |
NDAs: | 5 |
Finished Product Suppliers / Packagers: | 4 |
Raw Ingredient (Bulk) Api Vendors: | 63 |
Clinical Trials: | 22 |
Patent Applications: | 4,910 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for LOTEMAX |
Drug Sales Revenues: | Drug sales revenues for LOTEMAX |
What excipients (inactive ingredients) are in LOTEMAX? | LOTEMAX excipients list |
DailyMed Link: | LOTEMAX at DailyMed |
Recent Clinical Trials for LOTEMAX
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Thomas Chester, OD | Phase 4 |
Illinois College of Optometry | Early Phase 1 |
Dr Salouti Eye Research Center | Phase 4 |
Pharmacology for LOTEMAX
Drug Class | Corticosteroid |
Mechanism of Action | Corticosteroid Hormone Receptor Agonists |
Anatomical Therapeutic Chemical (ATC) Classes for LOTEMAX
US Patents and Regulatory Information for LOTEMAX
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Bausch And Lomb Inc | LOTEMAX | loteprednol etabonate | GEL;OPHTHALMIC | 202872-001 | Sep 28, 2012 | AB | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Pharmos | LOTEMAX | loteprednol etabonate | SUSPENSION/DROPS;OPHTHALMIC | 020841-001 | Mar 9, 1998 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Bausch And Lomb | LOTEMAX | loteprednol etabonate | OINTMENT;OPHTHALMIC | 200738-001 | Apr 15, 2011 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for LOTEMAX
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Bausch And Lomb | LOTEMAX | loteprednol etabonate | SUSPENSION/DROPS;OPHTHALMIC | 020583-001 | Mar 9, 1998 | ⤷ Try a Trial | ⤷ Try a Trial |
Bausch And Lomb | LOTEMAX | loteprednol etabonate | SUSPENSION/DROPS;OPHTHALMIC | 020583-001 | Mar 9, 1998 | ⤷ Try a Trial | ⤷ Try a Trial |
Pharmos | LOTEMAX | loteprednol etabonate | SUSPENSION/DROPS;OPHTHALMIC | 020841-001 | Mar 9, 1998 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for LOTEMAX
See the table below for patents covering LOTEMAX around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
European Patent Office | 0969812 | COMPOSITIONS OPHTALMIQUES COMPORTANT DE LA GLYCERINE ET DU PROPYLENE GLYCOL (OPHTHALMIC COMPOSITIONS INCLUDING GLYCERIN AND PROPYLENE GLYCOL) | ⤷ Try a Trial |
United Kingdom | 2079755 | ANDROSTENE 17 -CARBONATE 17 -CARBOXYLATES (AND CARBOTHIOATES) | ⤷ Try a Trial |
Germany | 69430635 | ⤷ Try a Trial | |
>Country | >Patent Number | >Title | >Estimated Expiration |